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The Frequency of Heteroplasmy in the HVII Region of mtDNA Differs
across Tissue Types and Increases with Age
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An immobilized sequence-specific oligonucleotide (SSO) probe system consisting of 16 SSO probes that detect
sequence polymorphisms within five regions of the mtDNA control region was used to investigate the frequency
of heteroplasmy in human mtDNA. Five regions of hypervariable region II (HVII) of the control region were studied
in blood-, muscle-, heart-, and brain-tissue samples collected from 43 individuals during autopsy. An initial search
for heteroplasmy was conducted by use of the SSO probe system. Samples in which multiple probe signals were
detected within a region were sequenced for the HVII region, to verify the typing-strip results. The frequency of
heteroplasmy was 5 of 43 individuals, or 11.6%. The frequency of heteroplasmy differed across tissue types, being
higher in muscle tissue. The difference in the frequency of heteroplasmy across different age groups was statistically
significant, which suggests that heteroplasmy increases with age. As a test for contamination and to confirm
heteroplasmy, the samples were sequenced for the HVI region and were typed by use of a panel of five polymorphic
nuclear markers. Portions of the tissues that appeared to be heteroplasmic were extracted at least one additional
time; all gave identical results. The results from these tests indicate that the multiple sequences present in individual
samples result from heteroplasmy and not from contamination.
Introduction
Since the human mitochondrial genome was completely
sequenced in 1981 by Anderson et al., analysis of mi-
tochondrial DNA (mtDNA) sequence variation has been
a favored tool for evolutionary studies. mtDNA has also
proven to be a useful target for the analysis of forensic
materials because of its high copy number and maternal
inheritance (Giles et al. 1980; Case and Wallace 1981).
In addition, the noncoding control region of the mito-
chondrial genome that includes the origin of H-strand
replication (Anderson et al. 1981), and two origins of
transcription (Cantatore and Attardi 1980) contain a
high degree of sequence variability between individuals.
The highest degree of polymorphism lies within two hy-
pervariable regions of the noncoding region, HVI and
HVII, that can be amplified and sequenced separately
(Aquadro and Greenberg 1983; Greenberg et al. 1983;
Piercy et al. 1993). Although these features of mtDNA
make it a particularly useful target for forensic analyses,
there are biological aspects of the organelle that need to
be considered to ensure that mtDNA typing results are
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interpreted appropriately; in particular, the presence of
more than one mtDNA sequence within an individual
(heteroplasmy) can lead to ambiguous results (Butler and
Levin 1998). Although most instances of heteroplasmy
have been observed in individuals with mitochondrial
diseases (Wallace 1992), individuals with more than one
mtDNA sequence have been observed in the normal pop-
ulation. Heteroplasmy is most often detected in the con-
trol region as length variation within the homopolymeric
tract of cytosine residues in the HVI and HVII regions
(Hauswirth and Clayton 1985; Bendall and Sykes 1995;
Bendall et al. 1996; Marchington et al. 1996, 1997).
Heteroplasmic point mutations were once thought not
to occur in the normal population (Monnat and Loeb
1985; Monnat and Reay 1986), but there is increasing
evidence that the frequency of these point mutations in
the normal population is significant (Gill et al. 1994;
Comas et al. 1995; Jazin et al. 1996; Parsons et al. 1997;
Calloway 1998).
Specialized laboratories currently use DNA sequence
analysis of the HVI and HVII regions for identification
of telogen hairs and the remains of missing persons
(Ginther et al. 1992; Sullivan et al. 1992; Holland et
al. 1993; Wilson et al. 1995a, 1995b; Allen et al. 1998).
This method of analysis has been also proposed for the
identification of mass disaster remains, which often con-
sist of a variety of small tissue samples from many in-
dividuals. Differences in the level of heteroplasmy across
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Table 1
Sequences of Primers Used to Amplify mtDNA Products
for the HVI and HVII Regions
Primer Pair
Primer Sequencea
(5′r3′)
1:
HVIL CTCCACCATTAGCACCCAA
HVIR ATTTCACGGAGGATGGTG
2:
HVIIL XCACCCTATTAACCACTCACG
HVIIR XCTGTTAAAAGTGCATACCGCCA
3:
L16521 TCTGGTTCCTACTTCAGGGTCA
H285 XGGGGTTTGGTGGAAATTTTTTTG
NOTE.—The three pairs of primers were used to amplify
the PCR products, as follows: HVIL and HVIR were used
to amplify a 444-bp product in the HVI region; HVIIL and
HVIIR were used to amplify a 415-bp product in the HVII
region; and L16521 and H285 were used to center the
heteroplasmic positions in the HVII region that were close
to the upstream primer.
a “X” denotes biotin label.
Table 2
Sequence Variation in the HVII Region, as Detected by 16 SSO
Probes
PROBEa
SEQUENCE VARIATION DETECTED AT POSITION
73 146 150 152 189 195 198 200 247 309.1
A1 A
A2 G
B1 T C T
B2 C C T
B3 T C C
B4 C C C
B5 T T T
B6 T T C
B7 C T C
C1 A T C A
C2 A C C A
C3 A C T A
C4 G T C G
D1 G
D2 A
E2 C
NOTE.—Regions A–D detect variation at 1–3 nt positions differing
from the Anderson (1981) sequence, and region E detects a length
variation within the HVII C stretch.
a Probes designated by a “1” correspond to the Anderson (1981)
sequence.
tissues, however, have been observed in individuals with
mtDNA diseases (Ciafaloni et al. 1991; Larsson et al.
1992). Therefore, prior to the routine use of mtDNA
typing in cases of mass disaster, the frequency of het-
eroplasmy and differences in levels across tissues from
individuals in the normal population should be deter-
mined. In the present study, tissue samples (heart, brain,
muscle, and blood) were collected upon autopsy from
43 individuals ranging in age from 11 to 85 years. The
extracted samples were typed by use of 16 immobilized
sequence-specific oligonucleotide (SSO) probes that de-
tect sequence variation within five regions of HVII. Het-
eroplasmy was detected by the immobilized probes in
one or more tissues from 5 of the 43 individuals and
was confirmed by sequence analysis of the HVII region.
The frequency and level of heteroplasmy clearly differed
across tissue types and the frequency of heteroplasmy
differed significantly with age.
Material and Methods
Collection of Samples
Postmortem tissue samples were collected from 43 in-
dividuals at the Georgia Bureau of Investigation (GBI)
morgue. A blood sample, as well as two heart and two
brain samples, were collected during autopsies of each
of the 43 individuals. A deep-muscle sample was col-
lected from 37 of the 43 individuals. The samples were
carefully collected by means of forceps that had been
soaked in 10% bleach for several minutes between col-
lection of each tissue sample. Tissue samples were stored
in 1.5-ml microcentrifuge tubes at 70C. Blood sam-
ples were stored at 4C in vials with EDTA to prevent
clotting.
Extractions
DNA from tissue and blood samples was extracted
utilizing Chelex 100 chelating resin (Walsh et al. 1991).
This protocol was modified for tissue extractions as fol-
lows: a small piece of tissue was placed into a screw-
cap tube, and 150 ml of sterile Nanopure water and 10
ml of 20 mg/ml proteinase K were added to the tube.
The sample was then incubated at 56C for 1.5 h.
Following the incubation, 50 ml of 20% Chelex solution
was added. Samples in which multiple sequences were
detected were extracted a second time, by the Chelex
extraction method. In addition, five replicate samples
from each collected tissue from several individuals (in-
cluding individuals 10, 13, and 43) were extracted by
an organic extraction method (Maniatis manual).
Quantitation and Amplification
Nuclear DNA was quantitated by the chemilumines-
cent method (Walsh et al. 1992). The amount of nuclear
DNA was estimated from slot blot analysis, and ∼1 ng
of DNA was amplified. The quantity of mtDNA added
is unknown and may be variable between different types
of tissues. The mtDNA was amplified in reactions con-
taining 12 mM Tris-HCl, pH 8.3, 60 mM KCl, 2.4 mM
MgCl2, 0.2 mM each dNTP, .25 U/ml AmpliTaq Gold
DNA polymerase (PE Biosystems), and 0.2 mM of each
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Table 3
Age, Race, Sex, and Mitotype of Each Individual, Sorted by Age
SAMPLE
AGEa
(years) RACE (SEX)
PROBE SIGNAL
FOR MITOTYPEb
A B C D E
25 ? White (M) 2 1 1W 1 0
39 ? African American (M) 1 1 0 2 0
41 11 White (M) 2 2 4 1 2
32 18 White (M) 1 1 2 1 2
8 19 African American (M) 2 0 2 1 2
11 23 White (F) 1W 1 2 1 2
12 23 African American (M) 2 7 0 0 0
47 24 White (M) 2 2 1 1 2
23 25 Asian (M) 2 1 2W 1 2
33 26 White (M) 1 1 1 1 0
35 26 African American (F) 2 7 4 1 0
9 31 White (M) 2 2 2 1 2
21 33 African American (F) 2 7 4 1 2
27 33 White (F) 2 1W 1 1 2
50 33 White (M) 2 1 1 1 0
49 35 White (M) 2 6 1 1 0
29 37 African American (M) 2 0 2 1 2
19 38 White (F) 2 5 1 1 0
46 38 White (M) 2 1W 2 1 2
16 39 White (M) 2 1 0 1 2
22 39 White (M) 2 1 1 1 0
24 39 White (M) 2 1 1 1 0
18 40 African American (M) 2 4 2 1 2
26 41 Asian (M) 2 5 1W 1 0
34 41 African American (M) 2 5!6 2 1 2
14 43 African American (M) 2 0 2 1 0
48 43 White (M) 2 5 1 1 0
37 45 White (F) 2 6 1 1 2
30 47 White (F) 2 1 1 1 2
7 48 White (M) 2 1 0 1 0
20 50 White (M) 2 1W 2 1 2
17 52 African American (F) 2 0 0 2 2
31 54 White (M) 2 1 1 1 0
44 55 White (M) 2 1 1W 1 0
40 56 African American (M) 2 4 1 1 0
42 57 White (M) 2 1 1 1 0
45 60 White (M) 1 1 1 1 2
28 63 White (M) 2 113 1 1 0
15 69 African American (F) 2 5 2 1 0
10 73 White (M) 112 1 1 1 2
13 81 White (M) 112 3 1 1 0
43 81 White (M) 112 1 1 1 0
38 85 White (M) 2 1 1 1 2
a A question mark (?) denotes that the age was unknown.
b Designations are as described in table 2. If two probe signals were
detected within a region in any tissue sample, both probes are indi-
cated, with the relative signal amount being indicated by an equality
sign. Except for individuals 10, 13, 28, 34, and 43, the single mitotype
listed for each individual in the table was observed in all tissue samples;
a summary of the mitotypes of these five individuals in whommultiple
probe signals were observed is presented in table 5. A weak probe
signal (designated by “W”) or no probe signal (designated by “0”)
may be observed if the sequence within the probe-binding region varies
from that of the probes (Reynolds et al., in press). For example, the
mitotype for sample 25 is as follows: A2, B1, C1W (the weak signal
observed indicated that this sequence varies at some position within
the probe-binding region, thereby affecting hybridization), D1, E0 (no
probe signal was observed; thus, there is no length difference vis-a`-vis
the Anderson [1981] sequence).
primer. Biotinylated primers, HVIIL and HVIIR (se-
quences are described in table 1) were used to amplify
a 415-bp PCR product. Primers L16521 and H285 (ta-
ble 1) were used to center the heteroplasmic positions,
which were near the HVIIL primer. To test for contam-
ination, primers HVIL and HVIR (table 1) were used to
amplify a 444-bp PCR product from the HVI region.
Each product was amplified by use of the following PCR
cycling conditions carried out in a programmable ther-
mal cycler (Perkin Elmer) model 9600: 1 cycle at 92C
for 12 min; 34 cycles of amplification, consisting of de-
naturation at 92C for 30 s, annealing at 60C for 30
s, and extension at 72C for 30 s; and 1 cycle at 72C
for 10 min. After amplification, the PCR product was
electrophoresed on a 1.75% agarose gel in the presence
of 1% TBE buffer containing ethidium bromide to de-
termine product yield.
SSO Probe System
An immobilized SSO probe system (Reynolds et al.,
in press) was used to detect heteroplasmy in the HVII
region. This system utilizes 17 SSO probes that are im-
mobilized on a nylon membrane: one SSO probe des-
ignated “S” serves as an intensity control, and 16 SSO
probes detect sequence polymorphisms within five
regions of the HVII (referred to as regions A–E). The S
probe corresponds to positions 362–394 of the Ander-
son (1981) sequence, which is relatively conserved across
populations and between individuals, and therefore all
amplified HVII products can hybridize to this probe. The
polymorphic positions detected by this system are listed
in table 2. Regions A–D detect 1–3-nt substitutions rel-
ative to the Anderson (1981) sequence, whereas region
E detects a length variation or insertion of one or more
cytosines at nt positions 303–309. If two probes from
the same region hybridized to the PCR product, heter-
oplasmy was suspected in that region for that sample.
Although some heteroplasmic mixtures will produce a
weaker E2 signal, heteroplasmy in region E (HVII C-
stretch heteroplasmy) is difficult to assess solely by the
SSO typing system, because there is only one probe in
region E. Therefore, heteroplasmy for this region is not
reported in this study. To confirm length heteroplasmy,
however, we are currently sequencing each sample.
The amount of PCR product was estimated from the
postamplification gel, and as much as 20 ml of the PCR
product was mixed with an equal amount of denaturing
solution (0.5 M sodium hydroxide). The hybridization
strips were labeled and placed in wells of the typing tray.
Three milliliters of hybridizing solution (5# SSPE,
0.5% SDS) was added to each well and incubated in a
rotating water bath at 55C for 10 min. Following each
hybridization and wash step, the solution was aspirated.
After the prehybridization wash step, the denatured PCR
product was added to 3 ml of the hybridization solution,
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Table 4
Observed Numbers of Heteroplasmic and Homoplasmic Individuals
of Each Age Group, Presented in a x2 Table, with Results
CATEGORY
NO. OF INDIVIDUALS IN AGE RANGE
11–35
years
36–60
years
61–85
years Total
Heteroplasmic 0 1 4 5
Homoplasmic 14 20 2 36
Total 14 21 6 41
NOTE.—A x2 test for independence and a randomization test was
conducted to determine whether the frequency of heteroplasmy dif-
fered significantly with age. On the basis of this data set, a x2 value
of 19.65 was obtained and P value associated with this x2 value and
2 df was highly significant, ; a randomization test was con-P 1 .005
ducted to obtain a more accurate P value, which also was also highly
significant, . Thus, it was determined that the frequency ofP = .00085
heteroplasmy differed significantly with age.
and the solution was added to wells containing the cor-
responding strip and incubated for 15 min. The hybrid-
ization strips were then rinsed with 3ml of wash solution
(2# SSPE, 0.5% SDS) by gently rocking the typing tray.
Three milliliters of conjugate solution (3.3 ml of hy-
bridization solution, 8 ml of SA-HRP conjugate per strip)
were added to each well and incubated for 5 min. The
hybridization strips were rinsed with 3 ml of wash so-
lution by rocking the typing tray. Three milliliters of
wash solution were added to each well and incubated
for 12 min at 55C. Afterward, the strips were rinsed
with 3 ml of wash solution by rocking the typing tray.
Three milliliters of 0.1 M citrate buffer, pH 5, were
added to each well, and the tray was placed on an orbital
shaker at 50 rpm for 5 min at room temperature. Three
milliliters of color-developing solution (3 ml of 0.1 M
citrate buffer pH 5.0, 3 ml of 3% H2O2, and 150 ml of
chromogen solution per strip) were added to each well.
The tray was then placed on an orbital shaker for ∼20
min or until the S control signal was visible. The hy-
bridization strips were washed three times with 3 ml of
Nanopure water for 5–10 min. Polaroid photographs
were taken of the wet strips overlaying an acetate in-
terpretation sheet.
Sequencing
The samples that appeared to be heteroplasmic were
sequenced to verify the results from the hybridization
strips. The HVI and HVII regions of the samples were
manually sequenced by the cycle-sequencing method us-
ing [33P]dATP and the AmpliCycle DNA sequencing kit
(Perkin Elmer) following the protocol recommended by
the manufacturer. A 6% acrylamide, 7 M urea gel was
electrophoresed for 1.5–3 h.
As a control, the HVII region of the heteroplasmic
samples was also sequenced in both the forward and
reverse directions by the Molecular Genetics Instrumen-
tation Facility at the University of Georgia with the ABI
Prism 373 Genetic Analyzer, following the recommended
protocol for the BigDye dye terminator chemistry. Mus-
cle and heart samples from individuals 10, 13, 28, and
43 were sequenced; heart and brain samples from in-
dividual 34 were sequenced. To confirm these results,
samples from a second extraction (heart, brain, muscle,
and blood) were also sequenced; the HVI and HVII
regions of these samples were sequenced by use of the
Big Dye sequencing kit (PE Biosystems) with the ABI
Prism 310 Genetic Analyzer following the recommended
protocol for the BigDye dye terminator chemistry. Se-
quencing data were analyzed by SEQUENCHER soft-
ware packages (Gene Codes Corporation).
AmpliType PM
In addition to sequence analysis of the HVI and HVII
regions, the AmpliType PM PCR Amplification and Typ-
ing kit (Perkin Elmer) was used to determine whether
the detected mixtures were due to contamination. The
AmpliType PM kit genotypes five loci simultaneously
and two unrelated individuals will have the same gen-
otypes !1% of the time (Budowle et al. 1995; Fildes and
Reynolds 1995). The protocol recommended by the
manufacturer was followed.
Statistical Analysis
A x2 test for independence and a randomization test
were used to determine whether the frequency of het-
eroplasmy differed significantly with age. Statistical
analysis to determine whether the frequency of hetero-
plasmy differed significantly with race or sex could not
be performed because the sample set was predomi-
nantly Caucasian males (table 3). Individuals were
grouped according to age in years into the following
categories: 11–35, (14 individuals); 36–60, (21 individ-
uals); and 61–85, (six individuals). The categories were
determined by dividing the range of ages into three equal
groups. The observed numbers of heteroplasmic and ho-
moplasmic for each of the three categories are presented
in the x2 in table 4. The ages, as well as the sex,2# 3
race, and mitotype, of each individual are noted in table
3. The ages of two individuals (indicated by a question
mark [?] in table 3) were not available; thus, these two
individuals were excluded from the statistical analysis.
To determine whether heteroplasmy differed with age,
a contingency table was constructed and x2 values2# 3
were calculated (Sokal and Rohlf 1995). A randomi-
zation test was used to determine the significance of the
calculated x2 value for the collected data (Manly 1997).
In this case, a randomization test was used to obtain a
more accurate P value, because probability estimates for
x2 tests can be inaccurate when cells contain five or fewer
individuals (Sokal and Rohlf 1995). Randomization ap-
proaches are powerful alternatives to analyze data when
the standard assumptions, such as minimum sample
Figure 1 Immobilized SSO probe strip and DNA sequencing results from a heteroplasmic individual. A, Immobilized SSO probe strip
results. The immobilized SSO probe system utilizes 16 SSO probes that detect sequence polymorphisms within five regions of the HVII, referred
to as regions A–E. Regions A–D detect 1–3 nt substitutions, and region E detects an insertion of one or more C residues within the HVII C
stretch (positions 303–309). Most samples have either one or no positive signal within each of the five regions. If two probes within a region
are observed, the sample contains a mixture of two sequences, a mixture that may be due to either contamination or heteroplasmy. For this
individual, the two probe signals observed in region B (B1 and B3) are due to heteroplasmy. Probe signals B1 and B3 are clearly observed in
the muscle- and brain-tissue samples. A B1 probe signal and a weaker B3 probe signal were observed in the heart and blood tissues of this
individual. Because the intensity of a probe signal correlates with the amount of DNA that hybridizes to a probe and is reflected in the S probe
signal, probe signals on the same strip can be compared to determine relative amounts of each sequence in the sample; however, because the
PCR-product input may vary between strips, absolute signals cannot be compared between strips. B, Sequence results for the region in which
multiple sequences were detected from all collected tissues from individual 28. Because the sequences of both sections of the heart and brain
tissues (designated as “1” and “2”) were identical, only results from heart 1 and brain 1 are presented. Sequence results verify the multiple
sequences observed by the SSO probe system. Multiple sequences (both T and C) were clearly detected by sequencing at position 152 in the
muscle and brain tissue of this individual. Although multiple probe signals were detected corresponding to this position in blood and heart
tissue, multiple sequences are not detected by sequencing. This observation may be explained by the greater sensitivity of the SSO probe system
relative to sequencing.
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Table 5
Mitotypes of Samples in Which Two SSO Probe
Signals Were Detected
SAMPLE
AND TISSUE
HVII MITOTYPE IN REGIONa
A B C D E
10:
Heart 1 1 1 1 2
Brain 1 1 1 1 2
Blood 1 1 1 1 2
Muscle 1 k 2 1 1 1 2
13:
Heart 1 3 1 1 0
Brain 1 3 1 1 0
Blood 1 3 1 1 0
Muscle 1 1 2 3 1 1 0
43:
Heart 1 1 1 1 0
Brain 1 1 1 1 0
Blood 1 1 1 1 0
Muscle 1 1 2 1 1 1 0
28:
Heart 2 1 k 3 1 1 2
Brain 2 1 1 3 1 1 2
Blood 2 1 k 3 1 1 2
Muscle 2 1 1 3 1 1 2
34:
Heart 2 6  5 2 1 2
Brain 2 6 1 5 2 1 2
Blood 2 6 1 5 2 1 2
a If two probe signals were detected within a re-
gion in any tissue sample, both probes are indicated,
with the relative signal amount being indicated by
an equality sign, as follows: “1” indicates that both
signals were clearly visible, with one being greater
than the other; “ ” indicates that a weak probek
signal from a secondary sequence was detected; and
“” denotes almost equal intensity. A zero (0) was
recorded if no probe signal was detected; for ex-
ample, the mitotype for sample number 10, muscle
tissue, is as follows: A1 and A2 (the detection of
the weak A2 probe signal indicates a low level of
a secondary sequence), B1, C1, D1, E2.
sizes, do not hold (Manly 1997). The randomization
approach was followed as described below. Within the
data set, each individual was assigned its real age. The
5 heteroplasmic states and 36 homoplasmic states were
then randomly reassigned among all individuals. From
this new, randomized data set, a new x2 value was cal-
culated. This procedure was repeated 20,000 times, re-
calculating new x2 values for each of the randomized
data sets. The probability P associated with the x2 test
of whether heteroplasmy varied with age was given by
the frequency of randomized x2 values that were greater
than or equal to the original x2 value.
Results
SSO Probe Analysis
The mtDNA typing strips shown in figure 1A (for
individual 28) are representative of results obtained from
a heteroplasmic individual. Heteroplasmy was suspected
if two probe signals within a region were observed. The
intensity of a probe signal generally reflects the amount
of DNA that hybridizes to the probe. Therefore, the two
probe signals within a region on the same strip can be
compared to determine relative amounts of each se-
quence in the sample. Absolute probe signals cannot be
compared between strips because different amounts of
PCR product may have been added to the strips, which
is reflected in the intensity of the S probe signal. Two
probe signals in region B (B1 and B3) were observed in
the tissue samples of the individual shown in figure 1A;
therefore, heteroplasmy was suspected in this region and
the samples were then sequenced to verify the typing
results.
Two probe signals were detected by the SSO probe
system in 5 of the 43 individuals. The typing strip results
from individuals in which two probes hybridized within
a region are presented in table 5. The probes that hy-
bridized to the particular sample for each region are
indicated by the corresponding probe number. Two
probe signals were clearly observed in region B of the
brain and muscle tissue of individual 28 shown in figure
1A. These probe sequences differ from each other at
position 152 and detect T or C at this position (table
2). In muscle tissue, the B3 probe signal was almost equal
in intensity to the B1 probe signal, whereas in the brain
sample, the B3 probe signal is weaker than the B1 probe
signal. A B1 probe signal and a very weak B3 probe
signal were observed in the blood and heart samples,
suggesting that all tissues from this individual are het-
eroplasmic but contain different ratios of the two se-
quences. Two probe signals were detected in all of the
sampled tissues (heart, brain, and blood; muscle tissue
was not collected) from individual 34 in region B, cor-
responding to probes 5 and 6. These probe signals differ
from the Anderson (1981) sequence at position 150 (T)
and differ from each other at position 152, detecting T
or C (table 2). The B5 probe signal (secondary mtDNA
type) is almost equal in intensity to the B6 probe signal
(primary mtDNA type) in the heart, whereas in the brain
and blood samples, the B5 probe signal is weaker than
the B6 probe signal.
Two probe signals were detected in region A of the
muscle samples of three individuals (10, 13, and 43)
corresponding to probes 1 and 2. These probes detect a
polymorphism at position 73 (table 2). In these three
individuals, two probe signals were observed in muscle
tissue but not in heart, brain, or blood tissue. In muscle
samples from these three individuals, a weak A2 probe
signal was observed. In the muscle tissue of individual
10, the A1 probe signal was significantly weaker relative
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Figure 2 Sequencing results from an individual with hetero-
plasmy at multiple positions and with a complete switch of mtDNA
sequences in the muscle tissue. Multiple sequences were observed at
three confirmed positions in the muscle tissue of this individual, 43.
Sequencing results from two of the heteroplasmic positions (72 and
73) are represented. The multiple sequences observed at position 73
were detected by the SSO probe system and correspond to region A.
Both A and G were detected at position 73 in the muscle tissue, as
expected on the basis of the SSO probe analysis. The G peak is off
center, but this result was found to be typical of multiple sequences
detected at this position. Sequencing analysis also revealed multiple
sequences at position 72 in the muscle tissue of this individual. In the
heart, brain, and blood, only a T was observed, whereas in the muscle
both C and T were observed at this position in the muscle tissue (Cr
T). Thus, a switch of predominant mtDNA sequences is observed in
the muscle tissue, compared with the other sequenced tissue samples.
Similar results were observed in individual 10.
to the probe signals in regions B–E, with only a very
faint or trace A2 probe signal present. Again, a weaker
A1 probe signal relative to the probe signals detected in
regions B–E, and a weak A2 probe signal was observed
in the muscle tissue of individual 43. Both an A1 probe
signal, which was almost of equal intensity in relation
to the probe signals detected in regions B–E, and a weak
A2 probe signal were observed in the muscle tissue of
individual 13. It is interesting to note that two probe
signals were detected only in the muscle tissue and in
the same region (corresponding to A and G at position
73) of these three individuals.
HVII-Region Sequencing Results
The HVII region from all available tissues from the
five individuals presented in table 6 were sequenced by
use of BigDye chemistry with the ABI Prism 310 Genetic
Analyzer to verify that the multiple sequences detected
by the typing strips were due to heteroplasmy. Prior to
implementing this sequencing method, some tissueswere
also sequenced manually or with the ABI Prism 373
Genetic Analyzer, as noted in table 6. When hetero-
plasmy was observed, the secondary base detected at a
position is noted in lowercase letters. If the peak heights
or signal intensity of the primary and secondary bases
were almost equal, both bases were noted in capital let-
ters; however, equivalent peaks do not necessarily in-
dicate equal amounts of the two sequences, because the
base-specific probe signals at a particular position can
be markedly different relative to a neighboring base.
Heteroplasmy was detected by sequence analysis in
the heart, brain, and blood tissue samples of individual
34. As expected from the mtDNA SSO probe typing
results, two sequences were detected at position 152 in
all collected tissues of this individual (corresponding to
the Anderson 1981) sequence. Two sequences were also
observed at position 152 of the muscle and brain tissues
of individual 28, but not in the blood or heart tissue
(fig. 1B). Only a trace of a secondary sequence was de-
tected in the brain tissue of this individual.
Individuals 10, 13, and 43 were heteroplasmic in mus-
cle tissue only. Although both A and G were expected
at position 73 (on the basis of SSO probe results), only
an A was observed by manual sequencing in these in-
dividuals. Both A and G were observed by automated
sequencing at position 73; however, the G peak was
almost undetectable. Sequencing results from individual
43 showing the A/G heteroplasmy at position 73 are
presented in figure 2. The absence of G at position 73
by manual sequencing and the low detection by auto-
mated sequencing may be explained by the greater sen-
sitivity of the SSO probe system compared to sequencing,
based on the observations of a mixture study (Reynolds
et al., in press). Reynolds et al. revealed that the ability
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to detect mixtures by automated sequencing varied from
position to position and that the SSO probe system was
more sensitive than sequencing. Specifically, at position
73, a mixture was detectable only at about a 20% level
by sequencing but at about a 10% level by typing.
Both manual and automated sequencing (both with
the ABI 373 and ABI 310) revealed a second hetero-
plasmic position within region A of these same three
individuals (10, 13, and 43). Two sequences were ob-
served at position 72, again only in the muscle tissue.
Figure 2 shows the T/C heteroplasmy at position 72 for
individual 43. Thus, the weaker A1 probe signal detected
by the SSO probe system can be explained by the C
present at position 72, which reduces the binding effi-
ciency of the product to the probe (Reynolds et al., in
press). The primary base detected in muscle tissue of
individual 13 was T. In contrast, the primary base in
muscle tissue from individuals 10 and 43 was C (fig. 2).
For these three individuals, only T was observed in heart,
brain, and blood. Therefore, in individuals 10 and 43,
the primary sequence in muscle has shifted from T to C
at position 72 (fig. 2).
Although the heteroplasmy described was observed in
both sequencing directions, positions 72 and 73 are close
to the upstream (HVII L) primer. A second primer set
(L16521 and H285 described in table 1) was designed
so that these positions would be centered in the PCR
product. Products from the heteroplasmic individuals
were typed and sequenced and identical results were ob-
served. From these results, a third possible heteroplasmic
position (C/A) was revealed at position 64 in individual
43. These products are being cloned and sequenced to
further characterize these multiple sequence variations.
In addition to the heteroplasmy detected at position
72, 73, and 152, an A/G heteroplasmy was detected by
both automated and manual sequencing at position 189
in the muscle tissue of individuals 10, 13, 28, and 43.
Sequencing data revealing heteroplasmy at position 189
for individuals 28 and 43 are presented in figure 3A and
B, respectively. A probe signal in addition to C1 was not
observed for these samples because the C2, C4, and C5
probes do not detect the mitotype of the secondary se-
quence (189 G, 195 T, 198 C, 200 A). The typing data
obtained from the SSO probe system is informative, but
it is limited to the five most variable regions within the
HVII region. Consequently, the frequency of hetero-
plasmy may be higher than detected in this study. Further
investigation of heteroplasmy by sequencing may yield
an increased frequency of heteroplasmy in regions un-
detectable by the SSO probe system. Additional studies
are underway to examine the frequency of heteroplasmy
by sequencing the remaining individuals who do not
appear to be heteroplasmic.
HVI-Region Sequencing Results
Sequencing of the HVI region of the heteroplasmic
individuals was conducted to confirm that the multiple
sequences detected in the HVII region were due to het-
eroplasmy and not contamination. If the mixtures were
due to contamination from another individual, the HVI
sequence would likely show mixtures at one or more
positions, since this region is highly polymorphic. Mul-
tiple sequences were not detected by manual or auto-
mated sequencing at any position in the HVI region,
suggesting that the multiple sequences observed in the
HVII region are not a result of contamination; however,
multiple sequences varying in the number of cytosine
residues in the HVI region (known as the “C stretch”)
were detected by both manual and automated sequenc-
ing in all collected tissues of individual 34 (table 6).
Because length heteroplasmy occurring in this stretch of
C residues has been well documented (Bendall and Sykes
1995; Bendall et al. 1996; Marchington et al. 1996,
1997), we concluded that the mixture of these length
variants was not due to contamination but rather to
heteroplasmy. Also, because five differences compared
to the Anderson (1981) sequence were detected in the
HVI region of this individual (table 6) and multiple se-
quences were not detected at any of these positions, the
C-stretch length variation is likely due to heteroplasmy
and not contamination.
AmpliType PM Results
Tissue samples from each of the heteroplasmic indi-
viduals were typed and the results were compared. Each
individual had a unique PM genetic profile. Therefore,
if contamination between individuals had occurred, it
would be detected on these SSO probe strips. Typing
results of the tissue samples within an individual were
identical, and no more than two alleles were observed
at the HBGG and GC loci (each have three common
alleles). These results suggest that the observed mixtures
in the HVII region are not a result of contamination or
sample mix-up.
Frequency Calculations
The percent of heteroplasmic individuals was calcu-
lated for each tissue type in the regions detected by the
SSO probe system and verified by sequencing. The
frequency of heteroplasmy was 5 of 43 individuals, or
11.6%, and differed across tissue types. The frequency
of heteroplasmy in muscle tissue was 4 of 37 individuals,
or 10.8%. (Note that this calculation does not include
the individual who was heteroplasmic for all tissues col-
lected, because no muscle tissue was collected from this
individual.) The frequency of heteroplasmy in the HVII
region was 2 of 43 individuals, or 4.7%, in brain tissue
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Figure 3 Sequencing results from two individuals with hetero-
plasmy at position 189 in the muscle tissue. Heteroplasmy was con-
firmed at position 189 in four of the five heteroplasmic individuals.
Heteroplasmy at this position was observed only in the muscle tissue;
muscle tissue was not collected from the fifth heteroplasmic individual.
Representative sequencing results of the multiple mtDNA sequences
observed at position 189 in the tissue samples sequenced from indi-
viduals 28 and 43 are presented (sequencing results of the other po-
sitions in which heteroplasmy was detected are presented in figs. 1B
and 2). Both A and G signals were observed at nearly equal ratios at
this position in muscle tissue.
and 1 of 43 individuals, or 2.3%, in blood and heart
tissue. (Note that this calculation does not include in-
dividual 28, in whom heteroplasmy was detected by the
SSO probes but not by sequencing.)
Statistical Test for Age and Heteroplasmy
The test of independence for association of hetero-
plasmy and age gave a significant x2 value of 19.65; the
probability P associated with this x2 value with 2 df was
highly significant (P 1 .005; table 4). To obtain a more
accurate P value, a randomization test was conducted.
The randomization test gave a highly statistically sig-
nificant P value of .00085 (table 4). Since highly signif-
icant P values were obtained from both tests, we con-
cluded that the frequency of heteroplasmy varies with
age. The mean age of homoplasmic individuals was 39.2
years, and the mean age of heteroplasmic individuals
was 69 years; thus, heteroplasmy in the HVII region
appears to increase with age.
Discussion
Confirmation of Observed Heteroplasmy
Heteroplasmy and the high risk of contamination pose
challenges to the interpretation ofmtDNA typing results,
whether obtained by SSO probe hybridization or se-
quence analysis. During the collection of autopsy sam-
ples and extraction of tissues, extensive measures to
prevent contamination were carried out. Both hetero-
plasmy and contamination may appear as a mixture of
sequences. Thus, without further information, hetero-
plasmy and contamination cannot readily be differen-
tiated. Therefore, following the collection of the samples,
replicate extractions and repeated amplifications and
typings were performed to confirm the initial results.
Five samples from each tissue type from individuals 43,
10, and 13 were typed, and the results were identical
for each replicate. On a different day, another portion
of each tissue from individual 43 was reextracted, ream-
plified, and retyped, and the results were identical to the
first five samples. Several months after the initial ex-
traction, a second extraction of one sample from each
tissue from all five heteroplasmic individuals was per-
formed. The samples were typed and sequenced, and
these results were also identical to the initial results.
Multiple samples in a blind format were amplified and
sequenced at a second location, again with identical re-
sults. Because the results were reproducible (the same
tissues, and no others, appeared to be heteroplasmic)
and multiple sequences were not detected by sequencing
the HVI region or typing by the AmpliType PM system,
the likelihood that the mixtures of mtDNA detected by
the SSO probe system are due to contamination is ex-
tremely low. In addition, since the HVI and HVII se-
quences of the analyst are unique, differing from all 43
individuals of this study, the multiple sequences observed
from the heteroplasmic samples cannot be explained by
contamination from the analyst (see table 6).
In addition to contamination, PCR replication error
and amplification of a nuclear pseudogene have been
proposed as other sources of multiple sequences. The
Table 6
HVI and HVII Sequence Variation Detected by Direct DNA Sequence Analysis Using ABI 310 and BigDye Dye Terminator Chemistry
SEQUENCE VARIATION INb
HVII HVI
64 72 73 114 146 150 152 189 195 263 309.1 315.1 16126 16129 17172 16183 16189 16192 16223 16224 16287 16294 16296 16304 16320
Referencea C T A C T C T A T A ) ) T G T A T C C T T C C T C
Samples:
10:
Heartc . . . . . . . . . G C C . A . . . . . . . . . . .
Brainc . . . . . . . . . G C C . A . . . . . . . . . . .
Blood . . . . . . . . . G C C . A . . . . . . . . . . .
Musclec . t/C A/g . . . . A/G . G C C . A . . . . . . . . . . .
13:
Heartc . . . . . . C . . G . C . . . . . . . . . . . . .
Brain . . . . . . C . . G . C . . . . . . . . . . . . .
Blood . . . . . . C . . G . C . . . . . . . . . . . . .
Muscle . T/c A/g . . . C A/G . G . C . . . . . . . . . . . . .
43:
Heartc . . . . . . . . . . . C . . . . . T . . . . . . .
Brain . . . . . . . . . . . C . . . . . T . . . . . . .
Blood . . . . . . . . . . . C . . . . . T . . . . . . .
Musclec C/a t/C A/g . . . . A/G . . . C . . . . . T . . . . . . .
28:
Heartc . . G . . . . . . G . C C . . . . . . . . T T C .
Brainc . . G . . . c/T . . G . C C . . . . . . . . T T C .
Blood . . G . . . . . . G . C C . . . . . . . . T T C .
Musclec . . G . . . c/T A/G . G . C C . . . . . . . . T T C .
34:
Heartc . . G . . T C/t . C G C C . . C C C * T . . . . . T
Brainc . . G . . T C/t . C G C C . . C C C * T . . . . . T
Blood . . G . . T C/t . C G C C . . C C C * T . . . . . T
Analystd . . . T C . C . C G . C . . . . . . . C C . . . .
a Anderson (1981)
b Sequencing was in both directions, by means of ABI 310 and BigDye dye terminator chemistry; if multiple signals were observed at a position, the predominant sequence is denoted by a
capital letter. Asterisks (*) denotes that, in all tissues collected from sample 34, a mixture of 10, 11, or 12 C’s was detected in the HVI C stretch.
c For HVII, tissue sample also was sequenced both by ABI 373 and manually, and, for HVI, tissue sample also was sequenced manually; in all cases, the multiple methods resulted in identical
sequences, confirming heteroplasmy.
d Also sequenced manually; in all cases, both methods resulted in identical sequences, confirming heteroplasmy.
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possibility that the mixtures of sequences are due to rep-
lication error during PCR is unlikely, because identical
results from duplicate amplifications were obtained.
Also, such errors are unlikely to occur predominantly
with DNA extracted from muscle tissue. The possibility
that the mixtures of sequences are attributable to am-
plification of a nuclear pseudogene is also unlikely. In
the present study, the highest number of observed het-
eroplasmic positions was three, and all three of these
positions were observed in the HVII region. To date, a
pseudogene has not been reported that corresponds to
the HVII region. There are, however, two well-charac-
terized nuclear insertions of a portion of the HVI region
into chromosomes 11 and 9 (Zischler et al. 1995, 1998).
Each of these insertions is ∼300 bp long. One of the
insertions differed by an average of 21 substitutions from
human mtDNA sequences and the other by more than
twice that number. Therefore, if an HVII pseudogene
had been coamplified, differences would most likely be
observed at a high proportion of the positions within
our 415-bp PCR product. To address directly the pos-
sibility that the results of this study are due to coam-
plification of a pseudogene corresponding to the HVII
region, the entire control region from the individuals
containing three putative heteroplasmic positions was
amplified by the HVIL and HVIIR primers, and the in-
dividual HVI and HVII regions were sequenced from
this PCR product. The results were identical to those
obtained with the original primer pair and the alternate
primer pair used to center the heteroplasmic positions,
and no additional mixtures were observed in either re-
gion (data not shown). If the observed mixture of se-
quences was due to coamplification of nuclear and mi-
tochondrial sequences, then the results obtained from
the entire control region product should have been dif-
ferent from the original 415-bp product results.
To address further the issue of a nuclear pseudogene,
mtDNA-free cells (r cells) and the parental cell line
143B were tested with PM nuclear primer pairs and our
HVII mtDNA primer pair. A portion of the cell pellets
(both r and parental) were extracted by use of the same
protocol that was used to extract the tissue samples for
our study. DNA from both the parental and r cell lines
was successfully amplified by the nuclear primer pairs,
showing that the nuclear DNA was not compromised
by the extraction method. The HVII mtDNA primer pair
was only successful in amplifying DNA from the paren-
tal strain and not from the mtDNA-free cells (data not
shown). Thus, this analysis is further evidence that a
nuclear pseudogene was not coamplified and supports
our initial conclusion that the multiple sequences we
observed are due to heteroplasmy. Therefore, we con-
cluded that the multiple sequences detected in specific
tissues by the SSO probe system and confirmed by se-
quencing can be attributed to heteroplasmy and not to
contamination, PCR replication error, or coamplifica-
tion of a nuclear pseudogene.
Forensic Implications of Increased Heteroplasmy with
Age and of Variation across Tissues
Most age-related mutation accumulation studies have
focused on the common deletion and point mutations
in the coding region (Cortopassi and Arnheim 1990;
Hattori et al. 1991; Corral-Debrinski et al. 1992; Cor-
topassi et al. 1992; Zhang et al. 1993; Melov et al.
1995). The deletion variant comprises !0.1% of the
mtDNA and has not been observed at a detectable level
by direct sequencing. In one case, a level of 10% was
reported in an 80-year-old individual (Corral-Debrinski
et al. 1992). Reports of an age-related accumulation of
point mutations in the coding region have been contra-
dictory; both age-related accumulations of point mu-
tations (Liu et al. 1998) and no correlation of point
mutations have been reported (Pallotti et al. 1996). The
preferred region of analysis for human identification ap-
plications, because of the high degree of polymorphism,
is the control region (specifically, noncoding regionsHVI
and HVII). Studies of heteroplasmy in the noncoding
region have been limited, however, both in the number
published and the number of samples analyzed. Jazin et
al. (1996) investigated heteroplasmy in the noncoding
region of brain samples in three individuals, using a very
sensitive method of detection (cloning); their study sug-
gests an increase in point mutations in the noncoding
region in brain tissue with age. In our study, point mu-
tation heteroplasmy in the noncoding region was inves-
tigated in four tissues of 43 individuals; the frequency
of heteroplasmy was highest in muscle tissue, and sta-
tistical analysis demonstrated a significant increase of
heteroplasmy with age (Calloway 1998). Our results do
not necessarily contradict the results of Jazin et al.
(1996), since they used a more sensitive detection
method and investigated heteroplasmy in various regions
of the brain. Results from our initial cloning studies with
all of the tissues are consistent with those of Jazin et.
al. and our original observations.
Because the frequency of heteroplasmy differed among
age groups and statistical analysis showed a significant
increase of heteroplasmy with age, the age of the indi-
vidual in question should be considered when inter-
preting mtDNA typing results. In particular, age and
heteroplasmy should be considered in missing person
cases when a significantly older individual is used as a
reference for a missing younger maternal relative. Again,
the frequency of heteroplasmy seemed to differ across
tissue types and appeared to be more frequent in muscle.
Thus, tissue samples other than muscle, if available,
should be typed when conducting mtDNA analysis for
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forensic cases to minimize the potential interpretation
issues associated with heteroplasmy.
Origin of Observed Heteroplasmy
A cell may become heteroplasmic through a germ line
or a somatic mutation; thus, heteroplasmy may be in-
herited or somatic. Heteroplasmy in humans was once
hypothesized to be due to paternal leakage, where the
father contributes a small number of mtDNA molecules
to the progeny. Although evidence for paternal leakage
has been observed in other organisms (Kondo et al.
1990; Gyllensten et al. 1991; Zouros et al. 1992), there
is no evidence that the paternal mtDNA makes any sig-
nificant genetic contribution in humans. Also, because
the primary and secondary mtDNA sequences observed
in the heteroplasmic individuals in this study are closely
related, the variant sequence of these individuals is
thought to have a mutational, rather than a paternal,
origin. Thus, in the case of heteroplasmy seen across all
tissue types in this study (individual 34), the most likely
mode of heteroplasmy is inheritance from the mother.
Because maternal samples were unavailable for testing,
the possibility that the observed heteroplasmy is a result
of an early mutational event in oogenesis or zygote de-
velopment must also be considered; however, somatic
mutation is unlikely, because heteroplasmy was detected
in all available tissues from this individual.
Heteroplasmy at position 152 observed in muscle and
brain tissues and detected by the SSO typing strips from
individual 28 is also likely due to an inherited hetero-
plasmy or a mutation prior to cell differentiation. Al-
though heteroplasmy was detected only in the brain and
muscle samples of this individual by fluorescent sequenc-
ing, a low level of heteroplasmy was detected by the SSO
typing strips in the heart and blood samples. Because
the SSO typing strips are more sensitive than sequencing
for detecting the presence of a second sequence, heter-
oplasmy in some tissues may be detected by the SSO
typing strips but not by sequencing. Therefore, hetero-
plasmy at position 152 is thought to occur in all tissues
of this individual; however, it should be noted that the
ratio of the secondary sequence to the primary sequence
differed between tissues (muscle 1 brain 1 heart/blood)
and that the level of the secondary sequence was 115%
in muscle and brain and ∼5%–10% in heart and blood.
Heteroplasmy was observed at position 189 in addi-
tion to position 152, in individual 28. In contrast to
position 152, heteroplasmy at position 189 was ob-
served only in muscle tissue (by both the SSO probe
system and sequencing), and the secondary sequencewas
observed at approximately a 50% level. Heteroplasmy
was also observed only in the muscle tissue of individuals
10, 13, and 43 at positions 72 and 73 as well as position
189; again, the secondary sequence detected at position
189 was observed at approximately a 50% level. Be-
cause heteroplasmy was observed only in muscle tissue
and at a high level by the SSO probe system sequencing
in these individuals, heteroplasmy was not reported for
the other tissues. Although heteroplasmy may possibly
occur at a level undetectable by both the SSO probe
system and sequencing in the other tissues, this ration-
alization cannot explain the increased level of the sec-
ondary sequence observed in muscle tissue compared to
other tissues. Therefore, heteroplasmy detected only in
the muscle samples is thought to be due to a somatic
mutation followed by an amplification event and not an
inherited mutation.
An increase in mtDNA mutations may be a result of
the production of oxygen radicals during oxidative phos-
phorylation, which is the primary source of energy for
several organs and tissues, including muscle, brain, and
heart (Wallace 1992). Tissues with high energy requi-
rements seem to accumulate mtDNA mutations more
readily; thus, in general, the accumulation of mtDNA
mutations is proportional to its metabolic rate (Shoffner
and Wallace 1995). An increase in mutation rate is not
sufficient to explain the increased level of heteroplasmy
in muscle. The mutation must be followed by an am-
plification event in order for the level of heteroplasmy
to be detectable (for the purposes of this study,
15%–10%). After a mtDNA mutation arises and the
heteroplasmic cell divides, its mtDNAs randomly seg-
regate into the daughter cells. After many cell divisions,
the random partitioning causes the molecules to drift
toward homoplasmy, known as “replicative segrega-
tion” (Wallace 1994). As a result of replicative segre-
gation, the level of heteroplasmy may vary within the
tissues of an individual (Wallace 1994). A germline mu-
tation or a mutation prior to cell differentiation followed
by replicative segregation may also result in a difference
in the level of heteroplasmy between tissues. The level
of heteroplasmy within a cell may vary even before cy-
tokinesis, because of the imprecise and nonrandom or
“relaxed” replication system (Birky 1994), also possibly
leading to a difference in the level of heteroplasmy be-
tween tissues. Recently Jenuth et al. (1997) have ob-
served tissue-specific segregation, whereby directional
segregation occurred in some tissues (one way in some
and in the opposite in others) while not occurring in
others. This observation, although observed in a mouse
model, may explain the increased level of heteroplasmy
observed in muscle tissue within an individual as well.
Future Studies
Because all of the heteroplasmic individuals from
whom muscle tissue was collected were heteroplasmic
at position 189 and the current SSO typing strips do not
detect this polymorphism, additional probes have been
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designed and further investigation and characterization
of heteroplasmy at this position are underway. Also, ad-
ditional studies to investigate the possibility that there
are heteroplasmic hot spots and to determine the fre-
quency of the occurrence of multiple heteroplasmic po-
sitions within the hypervariable region of an individual
are completed. Further characterization of the frequency
of heteroplasmy in the HVI and HVII regions across
tissue types and age groups by direct sequencing is also
completed. This information will be valuable for refining
existing interpretation guidelines for mtDNA of case-
work materials and of remains analysis of mass disaster.
Note added in proof.—After our work was submitted,
a manuscript by Michikawa et al. was submitted and
published in the October 22, 1999, issue of Science.
Their data are consistent with our findings.
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